SEC Form 4 · accession 0001127602-18-022784
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James C Foster
Officer — Chairman & CEO · Director
Period of report
Jul 2, 2018
Accepted (ET)
Jul 5, 2018 · 11:24 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 2, 2018 | S | 10 | $110.965 | D | 285,260 | D | |
| Common Stock | Jul 2, 2018 | S | 45 | $110.985 | D | 285,215 | D | |
| Common Stock | Jul 2, 2018 | S | 1 | $110.99 | D | 285,214 | D | |
| Common Stock | Jul 2, 2018 | S | 154 | $111.00 | D | 285,060 | D | |
| Common Stock | Jul 2, 2018 | S | 446 | $111.01 | D | 284,614 | D | |
| Common Stock | Jul 2, 2018 | S | 800 | $111.03 | D | 283,814 | D | |
| Common Stock | Jul 2, 2018 | S | 385 | $111.04 | D | 283,429 | D | |
| Common Stock | Jul 2, 2018 | S | 100 | $111.05 | D | 283,329 | D | |
| Common Stock | Jul 2, 2018 | S | 315 | $111.06 | D | 283,014 | D | |
| Common Stock | Jul 2, 2018 | S | 317 | $111.07 | D | 282,697 | D | |
| Common Stock | Jul 2, 2018 | S | 200 | $111.08 | D | 282,497 | D | |
| Common Stock | Jul 2, 2018 | S | 100 | $111.09 | D | 282,397 | D | |
| Common Stock | Jul 2, 2018 | S | 201 | $111.10 | D | 282,196 | D | |
| Common Stock | Jul 2, 2018 | S | 89 | $111.12 | D | 282,107 | D | |
| Common Stock | Jul 2, 2018 | S | 400 | $111.16 | D | 281,707 | D | |
| Common Stock | Jul 2, 2018 | S | 200 | $111.165 | D | 281,507 | D | |
| Common Stock | Jul 2, 2018 | S | 604 | $111.17 | D | 280,903 | D | |
| Common Stock | Jul 2, 2018 | S | 100 | $111.18 | D | 280,803 | D | |
| Common Stock | Jul 2, 2018 | S | 100 | $111.20 | D | 280,703 | D | |
| Common Stock | Jul 2, 2018 | S | 399 | $111.21 | D | 280,304 | D | |
| Common Stock | Jul 2, 2018 | S | 1 | $111.22 | D | 280,303 | D | |
| Common Stock | Jul 2, 2018 | S | 400 | $111.23 | D | 279,903 | D | |
| Common Stock | Jul 2, 2018 | S | 4 | $111.24 | D | 279,899 | D | |
| Common Stock | Jul 2, 2018 | S | 100 | $111.245 | D | 279,799 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This sale occurred pursuant to a 10b5-1 Trading Plan.